Banque Pictet & Cie’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-33,864
| Closed | -$300K | – | 596 |
|
|
2023
Q1 | $300K | Sell |
33,864
-45,825
| -58% | -$406K | ﹤0.01% | 531 |
|
|
2022
Q4 | $727K | Sell |
79,689
-847,729
| -91% | -$7.73M | 0.01% | 443 |
|
|
2022
Q3 | $7.48M | Sell |
927,418
-3,814
| -0.4% | -$30.8K | 0.08% | 122 |
|
|
2022
Q2 | $7K | Sell |
931,232
-44,578
| -5% | -$335 | 0.07% | 135 |
|
|
2022
Q1 | $9.16M | Buy |
975,810
+2,682
| +0.3% | +$25.2K | 0.07% | 128 |
|
|
2021
Q4 | $7.8M | Sell |
973,128
-9,723
| -1% | -$77.9K | 0.06% | 164 |
|
|
2021
Q3 | $9.57M | Sell |
982,851
-4,311
| -0.4% | -$42K | 0.1% | 92 |
|
|
2021
Q2 | $9.83M | Sell |
987,162
-8,042
| -0.8% | -$80.1K | 0.11% | 93 |
|
|
2021
Q1 | $11.3M | Buy |
995,204
+895,741
| +901% | +$10.2M | 0.15% | 87 |
|
|
2020
Q4 | $946K | Buy |
99,463
+39,768
| +67% | +$378K | 0.01% | 236 |
|
|
2020
Q3 | $541K | Sell |
59,695
-6,750
| -10% | -$61.2K | 0.01% | 250 |
|
|
2020
Q2 | $800K | Hold |
66,445
| – | – | 0.01% | 235 |
|
|
2020
Q1 | $612K | Buy |
+66,445
| New | +$612K | 0.01% | 246 |
|
|
2019
Q2 | – | Sell |
-60,994
| Closed | -$950K | – | 338 |
|
|
2019
Q1 | $950K | Sell |
60,994
-2,651
| -4% | -$41.3K | 0.02% | 218 |
|
|
2018
Q4 | $999K | Sell |
63,645
-47,532
| -43% | -$746K | 0.02% | 214 |
|
|
2018
Q3 | $2.44M | Buy |
111,177
+4,049
| +4% | +$88.8K | 0.05% | 177 |
|
|
2018
Q2 | $2.54M | Buy |
107,128
+12,338
| +13% | +$293K | 0.05% | 178 |
|
|
2018
Q1 | $1.61M | Buy |
+94,790
| New | +$1.61M | 0.03% | 224 |
|
|
2017
Q4 | – | Sell |
-106,449
| Closed | -$1.86M | – | 364 |
|
|
2017
Q3 | $1.86M | Buy |
106,449
+41,504
| +64% | +$726K | 0.04% | 211 |
|
|
2017
Q2 | $2.15M | Sell |
64,945
-407,438
| -86% | -$13.5M | 0.05% | 205 |
|
|
2017
Q1 | $15.5M | Buy |
+472,383
| New | +$15.5M | 0.38% | 53 |
|